Literature DB >> 17437671

Osteoporosis in men: pathophysiology and treatment.

Luigi Gennari1, John P Bilezikian.   

Abstract

Osteoporosis has long been long considered a disease of the aging female skeleton. However, it is now clear that men are also at risk for this disorder. Epidemiologic studies have confirmed that osteoporotic fractures in men are an increasing public health problem, in part due to increased longevity and increased public awareness. Recent large-scale population studies in men have led to advances in our understanding of bone fragility and its treatment in men. This article reviews what is known about the factors in men that lead to acquisition, maintenance, and loss of bone, as well as new insights into causes, pathogenesis, and treatment of osteoporosis in men.

Entities:  

Mesh：

Year:  2007        PMID： 17437671     DOI： 10.1007/s11926-007-0025-y

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


  48 in total

Review 1.  Genetics of osteoporosis.

Authors:  J A Eisman
Journal:  Endocr Rev       Date:  1999-12       Impact factor: 19.871

2.  Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men.

Authors:  S Khosla; L J Melton; E J Atkinson; W M O'Fallon
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

3.  Hormonal and biochemical determinants of trabecular microstructure at the ultradistal radius in women and men.

Authors:  Sundeep Khosla; L Joseph Melton; Sara J Achenbach; Ann L Oberg; B Lawrence Riggs
Journal:  J Clin Endocrinol Metab       Date:  2005-12-20       Impact factor: 5.958

Review 4.  The endocrinology of aging.

Authors:  S W Lamberts; A W van den Beld; A J van der Lely
Journal:  Science       Date:  1997-10-17       Impact factor: 47.728

5.  Mortality after all major types of osteoporotic fracture in men and women: an observational study.

Authors:  J R Center; T V Nguyen; D Schneider; P N Sambrook; J A Eisman
Journal:  Lancet       Date:  1999-03-13       Impact factor: 79.321

6.  Relationship of volumetric BMD and structural parameters at different skeletal sites to sex steroid levels in men.

Authors:  Sundeep Khosla; L Joseph Melton; Richard A Robb; Jon J Camp; Elizabeth J Atkinson; Ann L Oberg; Peggy A Rouleau; B Lawrence Riggs
Journal:  J Bone Miner Res       Date:  2004-12-20       Impact factor: 6.741

7.  LRP5 gene polymorphisms and idiopathic osteoporosis in men.

Authors:  S L Ferrari; S Deutsch; C Baudoin; M Cohen-Solal; A Ostertag; S E Antonarakis; R Rizzoli; M C de Vernejoul
Journal:  Bone       Date:  2005-09-15       Impact factor: 4.398

Review 8.  Clinical review 144: Estrogen and the male skeleton.

Authors:  Sundeep Khosla; L Joseph Melton; B Lawrence Riggs
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

9.  Alendronate treatment of established primary osteoporosis in men: results of a 2-year prospective study.

Authors:  J D Ringe; H Faber; A Dorst
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

Review 10.  Aromatase activity and bone homeostasis in men.

Authors:  Luigi Gennari; Ranuccio Nuti; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958
View more
  2 in total

1.  Approach in glucocorticoid-induced osteoporosis prevention: results from the Italian multicenter observational EGEO study.

Authors:  U Massafra; S Migliaccio; C Bancheri; F Chiacchiararelli; F Fantini; F Leoni; L S Martin; A Migliore; B Muccifora; C Napolitano; R Pastore; A Ragno; S Ronzoni; M Rotondi; M Tibaldi; P Villa; V Vinicola; E D'Erasmo; P Falaschi; G Minisola
Journal:  J Endocrinol Invest       Date:  2012-03-06       Impact factor: 4.256

Review 2.  Causes, consequences, and treatment of osteoporosis in men.

Authors:  Jameela Banu
Journal:  Drug Des Devel Ther       Date:  2013-08-22       Impact factor: 4.162
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.